91% of PE-backed company CFOs fear losing their job, a survey finds
”There is a lot of anxiety among CFOs,” says Nick Leopard, founder and CEO of Accordion.
Stay updated with breaking news from Roka Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
”There is a lot of anxiety among CFOs,” says Nick Leopard, founder and CEO of Accordion.
Zepbound is expected to be available in the U.S. by the end of the year.
/PRNewswire/ -- The "In Vitro Diagnostic Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering. In Vitro...
/PRNewswire/ -- The "Global In Vitro Diagnostics Partnering Terms and Agreements 2010-2023" report has been added to ResearchAndMarkets.com's offering. The...
/PRNewswire/ -- The "Global In Vitro Diagnostics Partnering Terms and Agreements 2010-2022" report has been added to ResearchAndMarkets.com's offering. The...